You are here

Article info

Article menu
Download PDFPDF
Editorial commentary
Active immunotherapy may delay disability in progressive MS

Authors

  1. Correspondence to Professor Ralf Gold, Department of Neurology, Ruhr-University Bochum, St. Josef-Hospital Bochum, Gudrunstrasse 56 Bochum 44791, Germany; ralf.gold{at}rub.de
View Full Text

Citation

Haghikia A, Gold R
Active immunotherapy may delay disability in progressive MS
Journal of Neurology, Neurosurgery & Psychiatry 2017;88:193.

Publication history

  • Received August 22, 2016
  • Accepted August 23, 2016
  • First published September 28, 2016.
Online issue publication 
February 17, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/